FDA Advisory Panel Evaluates Replimune Viral Immunotherapy for Melanoma

By Matthew Herper and Elaine Chen · STAT News · 2026-07-30

FDA Advisory Panel Evaluates Replimune Viral Immunotherapy for Melanoma

STAT News reports that the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee is meeting this Thursday to assess data for RP1, an engineered viral treatment for skin cancer. The biotech firm seeks accelerated approval for its candidate following a prior rejection in Ap

STAT News reports that the FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee is meeting this Thursday to assess data for RP1, an engineered viral treatment for skin cancer. The biotech firm seeks accelerated approval for its candidate following a prior rejection in Ap